Report #2827104

Received Feb 19, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: IL
Recovered: Not recovered
Vaccinated: Dec 30, 2024
Onset: Dec 30, 2024
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
TDAP	TDAP (BOOSTRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	M77CC	IM

Symptoms (1)

Myalgia

Symptom narrative

Pain seems to be in the patient's left bicep; This non-serious case was reported by a other health professional and described the occurrence of localized muscle pain in a 76-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number M77CC, expiry date 19-MAR-2027) for prophylaxis. On 30-DEC-2024, the patient received Boostrix (intramuscular) .5 ml. On 30-DEC-2024, an unknown time after receiving Boostrix, the patient experienced localized muscle pain (Verbatim: Pain seems to be in the patient's left bicep). The outcome of the localized muscle pain was not resolved. It was unknown if the reporter considered the localized muscle pain to be related to Boostrix. It was unknown if the company considered the localized muscle pain to be related to Boostrix. Additional Information: GSK receipt date: 13-JAN-2025 Other HCP reported that a patient had muscle pain which seem to be in the patient's left bicep.